-
Mashup Score: 02023 Move4Her - 7 month(s) ago
FWC Move4Her 2023 : Join Today!
Source: 2023-move4her.raisely.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 02023 Move4Her Fitness and Celebration Event Sizzle Reel - 7 month(s) ago
On Saturday, September 23, 2023, gynecologic cancer patients, care partners, survivors and advocates from across the country came together in Washington, D.C…
Source: www.youtube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The #Move4Her Event was a day full of motivation and unity. Thanks to all who joined us to support #GynCancer research and awareness. For those who couldn't attend, catch the inspiring sizzle reel here: https://t.co/PdyfenG4RX #MoveTheMessage
-
-
Mashup Score: 12023 Move4Her - 8 month(s) ago
FWC Move4Her 2023 : Join Today!
Source: 2023-move4her.raisely.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Each dollar raised for #Move4Her fuels advancements in #GynCancer treatment and care. With over $60 million raised to date, our collective efforts are driving vital #GynCancer research. Learn more about the movement and how you can make an impact at https://t.co/ylw7PxD9sg. https://t.co/xVKW0FWmxx
-
-
Mashup Score: 0Register • 2023 Move4Her - 9 month(s) ago
FWC Move4Her 2023 : Join Today!
Source: 2023-move4her.raisely.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Every 5 minutes, someone is diagnosed with 1 of the 5 gyn cancers; we hope to change that. Join us next month during #GCAM for a #Move4Her fitness event to raise funds and awareness about #gyncancer. Get early bird pricing through 8/25! https://t.co/cFx8WVQGgF #MoveTheMessage https://t.co/AL4cvrs22K
-
-
Mashup Score: 02023 Move4Her - 10 month(s) ago
FWC Move4Her 2023 : Join Today!
Source: 2023-move4her.raisely.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Have you registered for #Move4Her? Join the movement and help us #MoveTheMessage in the fight against #GynCancer. Save the date for a special fitness event in Washington DC on September 23! Enjoy early bird pricing through August 25. Register: https://t.co/ylw7PxD9sg https://t.co/7rieoqphkx
-
-
Mashup Score: 0
New research suggests that, for patients with ovarian cancer, the risk of VTE increases as patients receive more lines of chemotherapy.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Heavily treated patients with #ovariancancer may benefit from thromboprophylaxis. Presented at the @SGO_org #SGO23 Annual Meeting on Women’s Cancer. https://t.co/yyjL5DIMbh #SGOMTG #gynonc #gyncancer
-
-
Mashup Score: 0Abortion Restrictions May Affect More than 20% of Pregnant Cancer Patients in the US - 1 year(s) ago
More than 20% of US patients diagnosed with cancer during pregnancy may be unable to terminate that pregnancy due to abortion laws in their state, a new study suggests.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
More than 20% of US patients diagnosed with cancer during pregnancy may be unable to terminate that pregnancy due to abortion laws in their state, a new study presented at SGO 2023 suggests. #SGOMTG #gynonc #gyncancer https://t.co/vyWakD3mAG
-
-
Mashup Score: 1
Patients with advanced or recurrent endometrial cancer spend about 15% of their time addressing health care needs, and this time burden can have a negative effect on their quality of life, a study suggests.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Patients with advanced or recurrent endometrial cancer spend about 15% of their time addressing health care needs, and this time burden can have a negative effect on their quality of life, a study presented at SGO 2023 suggests. #SGOMTG #gynonc #gyncancer https://t.co/z030GYaPwj
-
-
Mashup Score: 2
Patients with advanced ovarian cancer may live longer if they undergo minimally invasive surgery rather than laparotomy, a study suggests.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Patients with advanced ovarian cancer may live longer if they undergo minimally invasive surgery rather than laparotomy, a study presented at SGO 2023 suggests. #SGOMTG #gynonc #gyncancer https://t.co/KKzw2vCE6f
-
-
Mashup Score: 0
Niraparib maintenance does not improve overall survival in patients with platinum-sensitive recurrent ovarian cancer, updated data suggest.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Niraparib maintenance does not improve overall survival in patients with platinum-sensitive recurrent ovarian cancer, updated data presented at SGO 2023 suggest. #SGOMTG #gynonc #gyncancer https://t.co/kSSoBVpWUx
-
️ Sending a high five 🖐️ to everyone moving and shaking for #Move4Her! Your efforts are taking the movement to new heights in the fight against #GynCancer. Want to make an impact? It's not too late to become a Move4Her fundraiser! https://t.co/ylw7PxD9sg https://t.co/5Bb02Oe8l4